Acceptance of preventive treatment in migraine patients: Results of a survey

References

• Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, . The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193–210.
   PubMed Web of Science ®Google Scholar
• Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology 1999;53:537–42.
   PubMed Web of Science ®Google Scholar
• Stewart WF, Wood GC, Razzaghi H, Reed ML, Lipton RB. Work impact of migraine headaches. J Occup Environ Med. 2008;50:736–45.
   Google Scholar
• Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005;118:3S–10S.
   PubMedGoogle Scholar
• Knuisting Neven A, Bartelink MEL, De Jongh TOH, Ongering JEP, Oosterhuis WW, Van der Weerd PCM, . NHG-standaard Hoofdpijn. Huisarts Wet. 2004;46:411–22.
   Google Scholar
• Ramadan N, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in the primary care setting: Pharmacological management for prevention of migraine; 2000. Available at http://www.neurology.org (accessed 27 January 2012).
   Google Scholar
• Couturier EGM, Bomhof MAM, Gooskens RHJM, Keyser A, Mulleners WM. Guidelines diagnosis and treatment of chronic recurrent headache (Dutch); 2007. Available at http://www. neurologie.nl (accessed 27 January 2012).
   Google Scholar
• Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, . EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol. 2009;16:968–81.
   PubMed Web of Science ®Google Scholar
• British Association for the Study of Headache.Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache; 2007. Available at www.bash.org.uk (accessed 27 January 2012).
   Google Scholar
• Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;30:343–9.
   Google Scholar
• Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study. Headache 2007;47:355–63.
   PubMed Web of Science ®Google Scholar
• Kol CM, Dekker F, Neven AK, Assendelft WJ, Blom JW. Acceptance or rejection of prophylactic medicine in patients with migraine: A cross-sectional study. Br J Gen Pract. 2008;58:98–101.
   PubMed Web of Science ®Google Scholar
• Smelt AF, Blom JW, Dekker F, van den Akker ME, Knuistingh NA, Zitman FG, . A proactive approach to migraine in primary care: A pragmatic randomized controlled trial. or Can Med Ass J 2012;184:E224–31.
   Google Scholar
• Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, . A six-item short-form survey for measuring headache impact: The HIT-6. Qual Life Res. 2003;12:963–74.
   PubMed Web of Science ®Google Scholar
• Donker T, Comijs H, Cuijpers P, Terluin B, Nolen W, Zitman F, . The validity of the Dutch K10 and extended K10 screening scales for depressive and anxiety disorders. Psychiatry Res. 2010;176:45–50.
   PubMed Web of Science ®Google Scholar
• Dekker F, Knuistingh Neven A, Andriesse B, Kernick D, Reis R, Ferrari MD, Assendelft WJ. Prophylactic treatment of migraine; the patient’s view, a qualitative study. BMC Fam Pract. 2012;13:13.
   Google Scholar
• Rozen TD. Migraine prevention: What patients want from medication and their physicians (a headache specialty clinic perspective). Headache 2006;46:750–3.
   PubMedGoogle Scholar
• Peres MF, Silberstein S, Moreira F, Corchs F, Vieira DS, Abraham N, . Patients’ preference for migraine preventive therapy. Headache 2007;47:540–5.
   Google Scholar
• Linde M, Jonsson P, Hedenrud T. Influence of disease features on adherence to prophylactic migraine medication. Acta Neurol Scand. 2008;118:367–72.
   Google Scholar
• Peters M, Abu-Saad HH, Vydelingum V, Dowson A, Murphy M. Patients’ decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia 2003;23:833–41.
   PubMed Web of Science ®Google Scholar
• Dekker F, Knuistingh Neven A, Andriesse B, Ferrari MD, Assendelft WJJ. Prophylactic treatment of migraine by GPs; a qualitative study. Br J Gen Pract. 2012;62:e268–74.
   Google Scholar
• Goodyear-Smith F, Kenealy T, Wells S, Arroll B, Horsburgh M. Patients’ preferences for ways to communicate benefits of cardiovascular medication. Ann Fam Med. 2011;9:121–7.
   PubMed Web of Science ®Google Scholar